Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

NeoStem Signs China Stem Cell Deal with Enhance BioMedical

publication date: Jun 15, 2009

NeoStem, Inc., a company built on collection and storage of adult stem cells, signed an exclusive 10-year agreement with Enhance BioMedical Holdings Limited of Shanghai. Using NeoStem developed techniques, Enhance will build a stem cell collection and treatment network. The facilities are targeted for Shanghai, Taiwan, and the provinces of Jiangsu, Zhejiang, Fujian, Anhui and Jiangxi. More details...

Stock Symbol: (NYSE Amex: NBS)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital